Here is the management team:
https://www.immutep.com/about-us/leadership-team.html
James Flinn responsible for patens management. Capital development are Jay Campbell & Grant Chamberlain have not done their jobs hence should be redundant.
Someone stated in disallowed that these experts are hired for a specialized task of bringing in conner stone investors. If not performing then they should be resigned.
As for more than 12,000 patients currently enrolled in the LAG3 programs, as you can see more than 9,000 are enrolled in BMS’s LAG3 trials
Here is the management...
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
35.5¢ |
Change
0.060(20.3%) |
Mkt cap ! $515.6M | |||
| Open | High | Low | Value | Volume |
| 36.0¢ | 37.5¢ | 33.5¢ | $6.427M | 18.03M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 50000 | 35.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 36.0¢ | 133736 | 5 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |